Hawthorne Katie, Drosou Maria Eleni, Shapiro Thomas A, Sicouri Serge, Gnall Eric M, Ramlawi Basel, Erten Ozgun, Sutter Francis, Dokollari Aleksander, Torregrossa Gianluca
Department of Cardiology, Lankenau Heart Center, Mainline Health, Wynnewood, PA (Drs Hawthorne, Drosou, and Shapiro).
Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA (Drs Sicouri, Ramlawi, Erten, Dokollari, and Torregrossa).
AJOG Glob Rep. 2023 Feb 17;3(2):100183. doi: 10.1016/j.xagr.2023.100183. eCollection 2023 May.
Outcomes of robotic-assisted coronary artery bypass grafting in pregnant women have not been assessed.
This study aimed to understand the importance of minimally invasive robotic-assisted coronary artery bypass grafting in pregnant woman with coronary artery disease. We describe the case of a G3P1011 woman at 19+6 weeks' gestation presenting with a non-ST myocardial infarction treated with off-pump hybrid robotic-assisted revascularization.
This study describes the surgical approach for a pregnant woman presenting with non-ST myocardial infarction treated with hybrid robotic-assisted revascularization.
A coronary angiography demonstrated a culprit lesion of 90% stenosis in the left anterior descending coronary artery and an 80% stenosis in the right coronary artery. Because of the high rate of complications with traditional coronary artery bypass grafting, the heart team opted for hybrid robotic-assisted revascularization and the postoperative recovery was uneventful.
Robotic coronary artery bypass grafting can be the preferred surgical choice to decrease maternal and fetal mortality in patients undergoing coronary artery bypass grafting, and it is an important tool in the surgical armamentarium.
尚未评估孕妇机器人辅助冠状动脉搭桥术的疗效。
本研究旨在了解微创机器人辅助冠状动脉搭桥术在患有冠状动脉疾病的孕妇中的重要性。我们描述了一名孕19 + 6周、孕3产1（G3P1011）的妇女，因非ST段心肌梗死接受非体外循环杂交机器人辅助血运重建治疗的病例。
本研究描述了一名患有非ST段心肌梗死的孕妇接受杂交机器人辅助血运重建治疗的手术方法。
冠状动脉造影显示，左前降支冠状动脉有一处罪犯病变，狭窄90%，右冠状动脉狭窄80%。由于传统冠状动脉搭桥术并发症发生率高，心脏团队选择了杂交机器人辅助血运重建，术后恢复顺利。
机器人辅助冠状动脉搭桥术可以成为降低接受冠状动脉搭桥术患者母婴死亡率的首选手术方式，并且是手术器械库中的一项重要工具。
